0000950170-23-073629.txt : 20231228
0000950170-23-073629.hdr.sgml : 20231228
20231228170904
ACCESSION NUMBER: 0000950170-23-073629
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231226
FILED AS OF DATE: 20231228
DATE AS OF CHANGE: 20231228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Prout Samantha
CENTRAL INDEX KEY: 0001743122
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33497
FILM NUMBER: 231523417
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS, INC.
STREET 2: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
FORMER NAME:
FORMER CONFORMED NAME: Prout Samantha Whiteman
DATE OF NAME CHANGE: 20180607
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMICUS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001178879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 200422823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3675 MARKET STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: (215) 921-7600
MAIL ADDRESS:
STREET 1: 3675 MARKET STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
FORMER COMPANY:
FORMER CONFORMED NAME: AMICUS THERAPEUTICS INC
DATE OF NAME CHANGE: 20020729
4
1
ownership.xml
4
X0508
4
2023-12-26
0001178879
AMICUS THERAPEUTICS, INC.
FOLD
0001743122
Prout Samantha
47 HULFISH STREET
PRINCETON
NJ
08542
false
true
false
false
Chief Accounting Officer
true
Common Stock
2023-12-26
4
S
false
7659
14.0003
D
121912
D
This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.00 to $14.005 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
All transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2023.
/s/ Christian Formica, Attorney-in-Fact
2023-12-28